TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.

Xiuning Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.